Skip to content

INBX - Inhibrx Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Inhibrx Biosciences, Inc.

INBX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

INBXInhibrx Biosciences, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $155.29
52-wk low: $24.00
Prev close: $85.43
Mkt cap: $1.49B
Beta: 3.52
P/S: 1000.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$416.6M

VG
Viking Global
Andreas Halvorsen · Q2 2026 13F
$106.5M
position
SC
Schonfeld
Steven Schonfeld · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 6.4% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.5B

Valuation

P/S1000.46
P/B212.28

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: INBX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.49B
Beta: 3.52

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

212.3x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-1774.0%

$66.1M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$13.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for INBX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$2.34+6.4%

-$2.50 expected

Next report

What the street expects next

EPS expected

-$2.39

-$2.39 to -$2.39

Revenue expected

$0.00

2 analysts

-1774.0%

ROA-43.6%

Growth

Beta3.52